View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
August 6, 2009

Merge Inks Contract With Confirma

Acquisition will open CAD imaging technology for the global healthcare market

By CBR Staff Writer

Merge Healthcare and Confirma have entered into an agreement for Merge to acquire Confirma in order to combine forces on expanding CAD technology.

This acquisition brings Confirma’s patented and proven technologies to Merge’s multiple market channels and international markets, and provides a mechanism to expand adoption of this important technology.

Justin Dearborn, CEO of Merge Healthcare, said: “CAD technology is still at an early adoption phase in the market for most indications, but it has significant opportunity as a tool for reducing imaging costs in today’s healthcare reform environment. Together with Confirma, we believe we can now better realize the long term global potential for this technology.”

Wayne Wager, CEO of Confirma, said: “Our customers understand the core benefits of CAD as a clinical workflow tool. By combining our patented CAD applications with Merge’s broader health IT solutions and global presence, we can better take advantage of current and future growth opportunities and, thus, extend our solutions to more clinicians.”

Content from our partners
Scan and deliver
GenAI cybersecurity: "A super-human analyst, with a brain the size of a planet."
Cloud, AI, and cyber security – highlights from DTX Manchester

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.